Methylergonovine Maleate Injection – Manufacturer, Exporter & Supplier
What is Methylergonovine Maleate Injection?
Methylergonovine Maleate Injection is an ergot alkaloid uterotonic used for the prevention and treatment of postpartum hemorrhage (PPH) due to uterine atony or subinvolution. By stimulating uterine smooth muscle contractions, it helps control excessive bleeding after childbirth. It is widely included in maternal health protocols across hospitals and emergency obstetric care units.
Uses of Methylergonovine Maleate Injection
- Prevention and treatment of postpartum hemorrhage (PPH)
- Management of uterine atony
- Control of subinvolution of the uterus
- Supportive therapy in obstetric surgeries such as cesarean section
- Rapid uterine contraction in obstetric emergencies
How Does Methylergonovine Maleate Injection Work?
Methylergonovine acts directly on the smooth muscle of the uterus, causing rapid and sustained contractions. This uterotonic effect reduces uterine bleeding and promotes involution of the uterus after delivery.
FAQs on Methylergonovine Maleate Injection
Q1: What is Methylergonovine Injection used for?
It is primarily used to prevent and control postpartum hemorrhage (PPH) after childbirth.
Q2: How is Methylergonovine Injection administered?
It is usually given by intramuscular (IM) or intravenous (IV) injection under medical supervision.
Q3: What precautions should be taken with Methylergonovine?
It should be used cautiously in patients with hypertension, preeclampsia, or cardiovascular disease.
Q4: Does Farbe Firma provide regulatory support for Methylergonovine exports?
Yes, we provide dossier (CTD/ACTD), COPP, and registration support for global submissions.
Looking for a reliable Methylergonovine Maleate Injection manufacturer?
Contact Farbe Firma Pvt. Ltd. for trusted maternal health injectables, dossier support, and worldwide export solutions.
Product Name
Methylergonovine Maleate Injection
Trade Name
Ergosyl
Available Strength
0.2 mg/ml
Packing
1 ml
Therapeutic Use
Postpartum hemorrhage (PPH) management, uterotonic agent

